Search Results
Dec 08, 2025, 14:45 ET Hemab Therapeutics Announces Positive Complete Phase 2 Data for Sutacimig in Glanzmann Thrombasthenia at ASH 2025; Plans to Advance to Pivotal Phase 3 Study
potential for people living with Glanzmann thrombasthenia, who have waited a lifetime for a modern prophylactic treatment," said Benny Sorensen, MD, PhD, Chief Executive Officer of Hemab. "The clinically meaningful reductions in bleeding demonstrated across this study provide compelling evidence
More news about: Hemab Therapeutics
Dec 08, 2025, 13:41 ET Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
therapy backbone in the combination setting," said Virginia Kaklamani, MD, DSc, Professor of Medicine in the Division of Hematology/Oncology at UT Health San Antonio, and Leader of the Breast Cancer Program at UT Health San Antonio MD Anderson Cancer Center. "The safety profile of elacestrant in combination
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 08, 2025, 13:30 ET Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
therapy backbone in the combination setting," said Virginia Kaklamani, MD, DSc, Professor of Medicine in the Division of Hematology/Oncology at UT Health San Antonio, and Leader of the Breast Cancer Program at UT Health San Antonio MD Anderson Cancer Center. "The safety profile of elacestrant in combination
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 08, 2025, 12:47 ET The Inner Circle acknowledges, Walter H. Halloran, MD, FACS as a Pinnacle Lifetime Member
medicine, service, and community.Dr. Halloran credits his mentors, Jack Delaney, MD, and Seymour Schwartz, MD, for shaping his career path. He honors the memory of his grandfather, Walter H. Halloran, MD, whose example inspired him to pursue medicine.Looking ahead, Dr. Halloran remains
More news about: The Inner Circle
Dec 08, 2025, 12:00 ET Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition
significant unmet need," said Naval G. Daver, M.D., professor and director of the Leukemia Research Alliance Program in the Department of Leukemia at MD Anderson Cancer Center in Houston. "The data from this ongoing Phase 1/2 study continue to show that enzomenib exhibits promising clinical activity,
More news about: Sumitomo Pharma America
Dec 08, 2025, 11:13 ET Children's Hospital of Philadelphia Researchers Identify Concerning Increase in Newborns Not Receiving Preventative Vitamin K Shots
Kristan Scott, MD, the study's lead author and a neonatologist in the
More news about: Children's Hospital of Philadelphia
Dec 08, 2025, 11:00 ET El Programa de Cannabis Medicinal reduce el consumo de opioides
investigadores de Montefiore Einstein fueron Chenshu Zhang, PhD; Yuval Zolotov, PhD; Joanna L. Starrels, MD, MS; Yuting Deng, PhD; Giovanna Calderon DiFrancesca, BA; Jonathan Ross, MD, MS; y Chinazo O. Cunningham, MD, MS.Logo -
More news about: Montefiore Health System
Dec 08, 2025, 10:30 ET ASTHO Announces Top Five Public Health Legislative Priorities for 2026
data-informed guidance that allows them to effectively address the nation's and territories' most urgent health challenges," says ASTHO CEO Joseph Kanter, MD, MPH. "This work is central to ASTHO's mission to advance the public's health and well-being. In 2026, infectious disease control and access to behavioral
More news about: Association of State and Territorial Health Officials
Dec 08, 2025, 10:30 ET Taiho Oncology Presents Data on All-Oral Regimens Azacitidine and Cedazuridine, and Decitabine and Cedazuridine at the 2025 American Society of Hematology Annual Meeting and Exposition
with lower-risk MDS may be comparable in safety and effectiveness to frequently used parenteral therapies for those populations," said Harold Keer, MD, PhD, Chief Medical Officer of Taiho Oncology. "While standard hypomethylating agents are administered via infusion in the clinic, these novel treatments
More news about: Taiho Oncology
Dec 08, 2025, 10:15 ET The American Diabetes Association Releases "Standards of Care in Diabetes--2026"
thereby equipping health care professionals with the tools necessary to provide optimal care for individuals living with diabetes," said Rita Kalyani, MD, MHS, the ADA's chief scientific and medical officer.Notable updates to the 2026
More news about: American Diabetes Association
Dec 08, 2025, 09:33 ET Tennessee's Newest Health and Wellness Sanctuary, Level, Celebrates the Holidays with Grand Opening on December 13th
this holiday season and celebrate a happy, healthy New Year."The Level leadership team includes:Dr. Dominic Papa (MD), Medical Director – A practicing physician with over 20 years of experience in integrative health and patient-centered care.Dr. Tom Burlage
More news about: Level
Dec 08, 2025, 09:19 ET SupplyHouse Announces 2025 Track to the Trades Scholarship Winners
— Lacey, WAChace Johnson — Cotton, MNMark Crosbourne — Brooklyn, NYNaethan Urtecho — Silver Springs, MDCorey Fields — Broadview, ILAungelique Simmons — Marietta, GAStephanie Reynolds-White — Denver, COAmanda
More news about: SupplyHouse
Dec 08, 2025, 09:05 ET Hip Innovation Technology Updates Orthopedic Community on its Reverse Hip Replacement System
V. Lombardi Jr., MD, FAAOS, JIS OrthopedicsDr. Lombardi will show a video of a Reverse HRS surgical procedure he conducted and offer insights about the procedure and the device.Thomas Turgeon, MD, Director of Arthroplasty
More news about: Hip Innovation Technology
Dec 08, 2025, 09:04 ET ALF Launches Partnership with Helio Genomics to Help Millions Affected by Liver Cancer
detection with innovative AI and easy at-home testing, empowering people to take charge of their health and prevent needless tragedy," said Bharat Tewarie, MD, MBA, CEO of Helio Genomics. "Our partnership with the American Liver Foundation sparks real hope, allowing individuals to detect liver cancer risks from
More news about: American Liver Foundation
Dec 08, 2025, 09:03 ET New Symptom-Management Guide Offers Practical Support for People Undergoing Metastatic Breast Cancer Treatment
care.""Effective symptom management is essential to ensuring patients can remain on treatment and maintain well-being," said Dr. Deborah Capko, MD, Breast Surgeon at Memorial Sloan Kettering Cancer Center. "This Guide provides clear, evidence-based information that supports meaningful conversations
More news about: Viver Health
Dec 08, 2025, 09:02 ET Navigate Appoints James Katz, MD and Caroline Watson, MD to Medical Advisory Board as Company Accelerates New Approach to Cataract Patient Education
FORT WORTH, Texas, Dec. 8, 2025 /PRNewswire/ -- Navigate announced today that James Katz, MD and Caroline Watson, MD have joined its Medical Advisory Board. Their appointment strengthens Navigate's efforts to help cataract surgeons grow their practices by
More news about: Navigate Patient Solutions
Dec 08, 2025, 09:00 ET Circular Genomics Strengthens Scientific Advisory Board with the Addition of Esteemed Alzheimer's Experts
the SAB also includes:Roy Perlis, MD, Director, Center of Experimental Drugs & Diagnostics, Massachusetts General Hospital; Professor of Psychiatry, Harvard Medical SchoolMadhukar Trivedi, MD, Chief of the Division of Mood Disorders and Director of the
More news about: Circular Genomics
Dec 08, 2025, 09:00 ET The Galien Foundation Honors 2025 Prix Galien Bridges Awards Recipients
ScienceEmma GUTTMAN-YASSKY, MD, PhDChair, Kimberly & Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount SinaiMansoor MIRZA, MDMedical Director, Nordic Society of Gynaecologic Oncology-Clinical Trial UnitAarno PALOTIE, MD, PhDResearch Director
More news about: The Galien Foundation
Dec 08, 2025, 09:00 ET Dr. Shawn Griffin recognized as one of Modern Healthcare's 100 Most Influential People in Healthcare
WASHINGTON, Dec. 8, 2025 /PRNewswire/ -- URAC is proud to announce that its President and CEO, Shawn Griffin, MD, was recognized by Modern Healthcare as one of the 100 Most Influential People in Healthcare of 2025. This marks Dr. Griffin's second consecutive year
More news about: URAC
Dec 08, 2025, 09:00 ET Lunit Submits 510(k) Application for Image-Based Breast Cancer Risk Prediction Model
adoption."Image-based risk assessment represents an important step toward making breast cancer prevention more precise and more accessible," said Graham Colditz, MD, DrPH, Professor of Washington University School of Medicine in St. Louis. "Our research has shown that mammography-derived five-year absolute risk can
More news about: Lunit
Dec 08, 2025, 08:37 ET A New Chapter in Hormone Health: Dr. Rachel Fishman Oiknine Brings MDVIP's Personalized Model to St. Louis
role model," she said. That legacy of connection continues to shape her practice today.About Rachel Fishman Oiknine, MD, MSCPDr. Fishman Oiknine earned her MD from the University of Missouri-Columbia School of Medicine in 2000 and completed her Endocrinology fellowship at Saint Louis
More news about: MDVIP
Dec 08, 2025, 08:36 ET BagMask.com Releases CRNA Salary by State 2025 Q4 Report
regional differences, and the highest paying states for Certified Registered Nurse AnesthetistsGAMBRILLS, Md., Dec. 8, 2025 /PRNewswire/ -- BagMask.com, the only anesthesia job board dedicated to empowering anesthesia professionals
More news about: BagMask.com
Dec 08, 2025, 08:35 ET Jody Casey Joins NAPA Anesthesia as Chief Growth Officer
roles within the healthcare, technology, and energy sectors. "Jody is a leader who knows how to create and scale," said Rafael Cartagena, MD, NAPA's Chief Executive Officer. "Her track record directly supports NAPA's vision to grow with purpose. I have no doubt she is ideally suited
More news about: NAPA Management Services Corporation
Dec 08, 2025, 08:30 ET First Capital Bank Welcomes Dr. Edward O'Bryan to Board of Directors
S.C., Dec. 8, 2025 /PRNewswire/ — First Capital Bank (OTCQX: FCPB) is pleased to announce that Edward O'Bryan, MD, MBA, CPE, has joined its Board of Directors. Dr. O'Bryan brings more than 25 years of experience in healthcare, business leadership, and strategic growth
More news about: First Capital Bank
Dec 08, 2025, 08:30 ET Spinogenix Reports Evidence of Rapid, Sustained Cognitive Improvement in Alzheimer's Patients from Phase 2a Trial of TAZBENTETOL (formerly SPG302)
2a study of Tazbentetol shows encouraging results for synaptic regeneration as a new treatment paradigm in Alzheimer's," said Professor Bruce Brew, MD, DSc, FRACP, FAAN, neurologist and principal investigator at St. Vincent's Hospital in Sydney, Australia who presented at CTAD. "These results show Tazbentetol's
More news about: Spinogenix